Literature DB >> 14636569

Regulation of BRCC, a holoenzyme complex containing BRCA1 and BRCA2, by a signalosome-like subunit and its role in DNA repair.

Yuanshu Dong1, Mohamed-Ali Hakimi, Xiaowei Chen, Easwari Kumaraswamy, Neil S Cooch, Andrew K Godwin, Ramin Shiekhattar.   

Abstract

We have isolated a holoenzyme complex termed BRCC containing BRCA1, BRCA2, and RAD51. BRCC not only displays increased association with p53 following DNA damage but also ubiquitinates p53 in vitro. BRCC36 and BRCC45 are novel components of the complex with sequence homology to a subunit of the signalosome and proteasome complexes. Reconstitution of a recombinant four-subunit complex containing BRCA1/BARD1/BRCC45/BRCC36 revealed an enhanced E3 ligase activity compared to that of BRCA1/BARD1 heterodimer. In vivo, depletion of BRCC36 and BRCC45 by the small interfering RNAs (siRNAs) resulted in increased sensitivity to ionizing radiation and defects in G2/M checkpoint. BRCC36 shows aberrant expression in sporadic breast tumors. These findings identify BRCC as a ubiquitin E3 ligase complex that enhances cellular survival following DNA damage.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14636569     DOI: 10.1016/s1097-2765(03)00424-6

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  116 in total

1.  BRCA1-dependent ubiquitination of gamma-tubulin regulates centrosome number.

Authors:  Lea M Starita; Yuka Machida; Satish Sankaran; Joshua E Elias; Karen Griffin; Brian P Schlegel; Steven P Gygi; Jeffrey D Parvin
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

Review 2.  Assembly, structure, and function of the 26S proteasome.

Authors:  Lynn Bedford; Simon Paine; Paul W Sheppard; R John Mayer; Jeroen Roelofs
Journal:  Trends Cell Biol       Date:  2010-04-26       Impact factor: 20.808

3.  Toward an integrated structural model of the 26S proteasome.

Authors:  Friedrich Förster; Keren Lasker; Stephan Nickell; Andrej Sali; Wolfgang Baumeister
Journal:  Mol Cell Proteomics       Date:  2010-05-13       Impact factor: 5.911

4.  Quantitative proteomic identification of the BRCA1 ubiquitination substrates.

Authors:  Meihua Song; Kevin Hakala; Susan T Weintraub; Yuzuru Shiio
Journal:  J Proteome Res       Date:  2011-10-11       Impact factor: 4.466

5.  USP11 Is a Negative Regulator to γH2AX Ubiquitylation by RNF8/RNF168.

Authors:  Miao Yu; Kun Liu; Zebin Mao; Jianyuan Luo; Wei Gu; Wenhui Zhao
Journal:  J Biol Chem       Date:  2015-10-27       Impact factor: 5.157

6.  Genomic analysis of snub-nosed monkeys (Rhinopithecus) identifies genes and processes related to high-altitude adaptation.

Authors:  Li Yu; Guo-Dong Wang; Jue Ruan; Yong-Bin Chen; Cui-Ping Yang; Xue Cao; Hong Wu; Yan-Hu Liu; Zheng-Lin Du; Xiao-Ping Wang; Jing Yang; Shao-Chen Cheng; Li Zhong; Lu Wang; Xuan Wang; Jing-Yang Hu; Lu Fang; Bing Bai; Kai-Le Wang; Na Yuan; Shi-Fang Wu; Bao-Guo Li; Jin-Guo Zhang; Ye-Qin Yang; Cheng-Lin Zhang; Yong-Cheng Long; Hai-Shu Li; Jing-Yuan Yang; David M Irwin; Oliver A Ryder; Ying Li; Chung-I Wu; Ya-Ping Zhang
Journal:  Nat Genet       Date:  2016-07-11       Impact factor: 38.330

7.  BRCA1 and BRCA2 in breast cancer predisposition and recombination control.

Authors:  Ralph Scully; Anyong Xie
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-07       Impact factor: 2.673

8.  BRCA1/BARD1 inhibition of mRNA 3' processing involves targeted degradation of RNA polymerase II.

Authors:  Frida E Kleiman; Foon Wu-Baer; Danae Fonseca; Syuzo Kaneko; Richard Baer; James L Manley
Journal:  Genes Dev       Date:  2005-05-15       Impact factor: 11.361

9.  Identification and characterization of missense alterations in the BRCA1 associated RING domain (BARD1) gene in breast and ovarian cancer.

Authors:  M K Sauer; I L Andrulis
Journal:  J Med Genet       Date:  2005-08       Impact factor: 6.318

Review 10.  The multiple layers of ubiquitin-dependent cell cycle control.

Authors:  Katherine Wickliffe; Adam Williamson; Lingyan Jin; Michael Rape
Journal:  Chem Rev       Date:  2009-04       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.